Pecoraro Alessio, Territo Angelo, Gallioli Andrea, Basile Giuseppe, Vangeneugden Joris, Etcheverry Begoña, Musquera Mireia, Lopez DE Mesa Rodriguez Byron, Prudhomme Thomas, Mercier Jeremy, Ortved Milla, Zeuschner Philip, Volpe Alessandro, Garcia-Baquero Rodrigo, Kocak Burak, Idu Mirza, Stockle Michael, Rohrsted Malene, Canda Albdullah E, Røder Andreas, Alcaraz Antonio, Doumerc Nicolas, Vigues Francesc, Decaestecker Karel, Masieri Lorenzo, Serni Sergio, Breda Alberto, Campi Riccardo
Unit of Urological Minimally Invasive, Robotic Surgery and Kidney Transplantation, Careggi Hospital, University of Florence, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Minerva Urol Nephrol. 2025 Jun;77(3):320-329. doi: 10.23736/S2724-6051.25.06279-2.
Kidney transplantation using right-sided graft (RSG) is technically challenging and may be associated with increased risk of complications and/or suboptimal graft function. Our study aims to compare perioperative and functional outcomes of robot-assisted kidney transplantation (RAKT) using RSG vs. left-sided graft (LSG).
The multi-institutional, prospectively collected EAU Robotic Urology Section (ERUS)-RAKT database was queried to select consecutive patients undergoing RAKT from living donors between 7/2015 and 11/2023. Intraoperative outcomes and early (30 days) postoperative complications and functional results were the main study end-points. Dialysis-free survival was explored as a secondary outcome.
Overall, 624 RAKTs were included, of which 526 (84%) using LSGs and 98 (16%) using RSGs. Preoperative characteristics did not significantly differ between the RSG and LSG groups. The median console time did not differ between the two groups while the use of RSGs was associated with a longer median rewarming time (46 vs. 43 min). No difference in intraoperative adverse events and postoperative high-grade complications between the two groups were reported (4% vs. 5.4%, P=0.4). At multivariable analysis, kidney side did not predict high-grade complications; the only significant factor predicting this outcome was the Centre's experience in RAKT (measured by the case number). RAKT achieved similar dialysis-free survival rates using LSGs and RSGs.
In experienced centers, RAKT using RSG from living donors is safe and achieves favorable perioperative and mid-term functional outcomes. While larger studies with longer follow-up are needed to confirm our findings, our study can influence the practice of living donor nephrectomy if RAKT is available.
使用右侧供肾(RSG)进行肾移植在技术上具有挑战性,并且可能与并发症风险增加和/或移植肾功能欠佳有关。我们的研究旨在比较使用RSG与左侧供肾(LSG)的机器人辅助肾移植(RAKT)的围手术期和功能结局。
查询多机构前瞻性收集的欧洲泌尿外科学会机器人泌尿外科分会(ERUS)-RAKT数据库,以选择2015年7月至2023年11月期间接受活体供者RAKT的连续患者。术中结局、术后早期(30天)并发症和功能结果是主要研究终点。将无透析生存期作为次要结局进行探讨。
总体而言,纳入了624例RAKT,其中526例(84%)使用LSG,98例(16%)使用RSG。RSG组和LSG组的术前特征无显著差异。两组的中位控制台时间无差异,而使用RSG与中位复温时间较长相关(46分钟对43分钟)。两组术中不良事件和术后高级别并发症无差异(4%对5.4%,P = 0.4)。在多变量分析中,供肾侧不能预测高级别并发症;预测这一结局的唯一显著因素是中心在RAKT方面的经验(以病例数衡量)。使用LSG和RSG的RAKT无透析生存率相似。
在经验丰富的中心,使用活体供者的RSG进行RAKT是安全的,并能实现良好的围手术期和中期功能结局。虽然需要更大规模、随访时间更长的研究来证实我们的发现,但如果有RAKT可用,我们的研究可能会影响活体供肾切除术的实践。